Author:
Veerman G.D.Marijn,van der Werff Sanne C.,Koolen Stijn L.W.,Miedema Jelle R.,Oomen-de Hoop Esther,van der Mark Sophie C.,Chandoesing Prewesh P.,de Bruijn Peter,Wijsenbeek Marlies S.,Mathijssen Ron H.J.
Subject
Pharmacology,General Medicine
Reference43 articles.
1. European Medicines Agency, Summary of Product Characteristics, Vargatef, January 8, 2015. Reference EMA/CHMP/726072/2014.
2. US Food & Drug Administration, label OVEF (nintedanib). September 2019. Reference ID 4572087.
3. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis;Richeldi;New Engl. J. Med.,2014
4. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review;Hutchinson;Eur. Respir. J.,2015
5. Idiopathic pulmonary fibrosis;Lederer;New Engl. J. Med.,2018
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献